摘要
目的观察体外膜肺氧合(ECMO)治疗重症急性呼吸衰竭的临床疗效,探讨影响ECMO治疗效果的相关因素。方法回顾性分析因重症急性呼吸衰竭接受ECMO治疗的患者32例,其中成功组25例,失败组7例。记录所有患者ECMO治疗前一般情况、ECMO期间血气分析、血流动力学以及急性生理与慢性健康状况评分Ⅱ(APACHEⅡ)等。结果成功组患者治疗前APACHEⅡ评分明显低于失败组(P<0.05),治疗后两组患者APACHEⅡ评分均明显下降。两组患者接受ECMO治疗后心率、呼吸频率、氧合指数均较治疗前有明显改善。结论 ECMO是重症急性呼吸衰竭的有效治疗手段。APACHEⅡ是影响ECMO治疗效果的重要因素。
Objective To observe the efficacy of extracorporeal membrane oxygenation（ ECMO） treatment on severe acute respiratory failure,and to explore the factors associated with prognosis. Methods Thirty-two patients with severe acute respiratory failure treated by ECMO were retrospectively analyzed,among whom 25 patients were successfully treated（ success group） and 7 patients failed（ failure group）. General conditions prior to ECMO,blood gas analysis,hemodynamics,acute physiology and chronic health evaluation Ⅱ（ APACHEⅡ） scores during ECMO of all patients were recorded. Results The APACHE Ⅱ scores prior to ECMO of patients in success group were lower than those in failure group（ P〈0. 05）. The APACHEⅡ scores of both groups were significantly decreased after ECMO. Heart rate,respiratory rate and oxygenation index of patients in both groups were significantly improved after ECMO. Conclusion VV-ECMO is an effective treatment for severe acute respiratory failure. APACHE Ⅱ score is an important factor that affects the ECMO efficacy.
出处
《中国临床新医学》
2016年第1期52-54,共3页
CHINESE JOURNAL OF NEW CLINICAL MEDICINE
关键词
体外膜肺氧合
呼吸衰竭
APACHEⅡ
Extracorporeal membrane oxygenation（ECMO）
Respiratory failure
APACHEⅡ
